Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026)
Valneva SE's (VALN) quarterly Interest Coverage Ratio came in at 5.44 in Q1 2026, up 34.21% year-on-year from 4.06 in Q1 2025, and up 36.06% quarter-over-quarter from 8.51 in Q4 2025.
Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Interest Coverage Ratio across 6 years of filings, most recently posting 5.44 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 5.44, up 34.21% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.2 (down 59.86% YoY), and the FY2025 annual result was 1.96, down 452.61% from the prior year.
- Interest Coverage Ratio came in at 5.44 for Q1 2026 at Valneva SE, up from 8.51 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 37.92 in Q2 2022 to a low of 27.69 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 4.94 (2024), against an average of 3.21.
- Across the five-year window, Interest Coverage Ratio soared 163.46% in 2022 and tumbled 551.08% in 2024, its largest moves.
- Valneva SE's Interest Coverage Ratio stood at 1.74 in 2022, then sank by 144.9% to 4.25 in 2023, then sank by 551.08% to 27.69 in 2024, then surged by 69.25% to 8.51 in 2025, then soared by 36.06% to 5.44 in 2026.
- The last three Interest Coverage Ratio figures came in at 5.44 (Q1 2026), 8.51 (Q4 2025), and 1.46 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -5.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.44 |
| Dec 31, 2025 | -8.51 |
| Sep 30, 2025 | 1.46 |
| Jun 30, 2025 | -8.18 |
| Mar 31, 2025 | -8.27 |
| Dec 31, 2024 | -27.69 |
| Sep 30, 2024 | 1.59 |
| Jun 30, 2024 | -8.37 |
| Mar 31, 2024 | -4.94 |
| Dec 31, 2023 | -4.25 |
| Sep 30, 2023 | -12.20 |
| Jun 30, 2023 | 4.86 |
| Mar 31, 2023 | 3.25 |
| Dec 31, 2022 | -1.74 |
| Sep 30, 2022 | -17.96 |
| Jun 30, 2022 | 37.92 |
| Mar 31, 2022 | 3.90 |
| Dec 31, 2021 | 6.06 |
| Sep 30, 2021 | 40.86 |
| Jun 30, 2021 | 14.39 |